Quantcast
Last updated on April 18, 2014 at 16:31 EDT

Latest gout Stories

2012-05-22 06:25:08

PITTSBURGH, May 22, 2012 /PRNewswire/ -- New recommendations from the American Society of Clinical Rheumatologists (ASCR), published in Postgraduate Medicine[1], highlight updated management recommendations for patients with acute gout. These new recommendations come at a time when the incidence of gout is soaring; 8.3 million Americans are estimated to be gout patients[2]. To view the multimedia assets associated with this release, please visit:...

2012-05-22 02:27:24

BRIDGEWATER, N.J., May 22, 2012 /PRNewswire/ -- An online survey conducted by Red Hot Mamas North America, Inc. found that women and their loved ones are significantly affected by very painful bouts of gout, which they consider to be chronic and severe. Respondents indicated that although the debilitating pain associated with the condition affects quality of life, many individuals are prescribed medications meant to control the condition which they are not taking. Red Hot...

2012-05-17 10:26:02

ISELIN, N.J., May 17, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout. This phase 2a trial was conducted at the Duke Clinical Research Unit of Duke University and the principal investigator was John Sundy, MD, PhD, an expert and key opinion leader in the treatment of gout. The trial was designed to assess...

2012-05-08 10:27:31

TARRYTOWN, N.Y., May 8, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against approval of ARCALYST® (rilonacept) Injection for Subcutaneous Use for the proposed indication for the prevention of gout flares in patients initiating uric acid-lowering therapy. The Committee's recommendation will be considered by the FDA in its review of the supplemental...

2012-05-02 13:19:51

Obese people who consume increased amounts of fructose, a type of sugar that is found in particular in soft drinks and fruit juices, are at risk for nonalcoholic fatty liver disease (NFALD) and more its more severe forms, fatty inflammation and scarring. Now researchers at Duke University Medical Center believe they better understand what mechanism may account for fructose-related liver injury. Chronic fructose consumption in a diet puts people at risk for depleting their store of...

2012-05-01 13:56:11

Teens with high levels of uric acid appear to be at increased risk for high blood pressure, according to results of research from scientists at Johns Hopkins Children´s Center. Although the findings do not establish a cause-and-effect link between uric acid and high blood pressure, they point to uric acid as one potential mechanism, or at least a biomarker, of disease, the researchers report in the April issue of the journal Hypertension. Analyzing more than 6,000 medical records...

2012-04-24 06:26:49

PHILADELPHIA and LONDON, April 24, 2012 /PRNewswire/ -- In just over a year, Gout Study on Facebook has exceeded 50,000 'likes' making it the largest online gout community globally. With nearly a quarter of its members from outside the U.S., its rapid rise in popularity demonstrates a keen interest in exchanging information and sharing experiences among those afflicted by this painful condition. Once thought to be a disease that affected those living a life of indulgence; fine food and...

2012-04-16 02:28:45

ISELIN, N.J., April 16, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today reported financial results for the first quarter ended March 31, 2012. The Company recorded a net loss of $0.6 million, or $(0.01) per share, for the first quarter 2012 compared to a net loss of $0.6 million, or $(0.01) per share, in the first quarter 2011. The Company is currently conducting a clinical trial at the Duke Clinical Research Unit to evaluate levotofisopam as a treatment for gout. As of...

2012-04-12 06:24:59

BALTIMORE, April 12, 2012 /PRNewswire/ -- Joint health affects a wide demographic -- from the young athlete who is experiencing runner's knee to the middle-aged health-conscious consumer looking to take a proactive approach to maintain joint health to the senior citizen experiencing painful arthritis in any number of joints. Whatever the reason for joint health concerns or pain, Egcel 5 Joint Health with NEM®( )offers a solution. Egcel 5 Joint Health with NEM®( )is a joint supplement...

2012-04-11 02:24:21

DEERFIELD, Ill., OSAKA, Japan, and PHILADELPHIA, April 11, 2012 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and URL Pharma Inc. (URL Pharma) jointly announced today that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma - a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent...